Dilated Cardiomyopathy Pipeline Review, H2 2018 - Therapeutic Assessment of 8 Companies - ResearchAndMarkets.com

DUBLIN--()--The "Dilated Cardiomyopathy - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Dilated Cardiomyopathy - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Dilated Cardiomyopathy (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 4, 5 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Dilated Cardiomyopathy (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Report Coverage
  3. Dilated Cardiomyopathy - Overview
  4. Dilated Cardiomyopathy - Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Pipeline by Universities/Institutes
  8. Products under Development by Companies
  9. Products under Development by Universities/Institutes
  10. Dilated Cardiomyopathy - Therapeutics Assessment
  11. Assessment by Target
  12. Assessment by Mechanism of Action
  13. Assessment by Route of Administration
  14. Assessment by Molecule Type
  15. Dilated Cardiomyopathy - Companies Involved in Therapeutics Development
  • Array BioPharma Inc
  • C&C BioPharma LLC
  • Capricor Therapeutics Inc
  • Celixir Ltd
  • Hemostemix Inc
  • Kasiak Research Pvt Ltd
  • MyoKardia Inc
  • Sanofi

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/rz4x3x/dilated?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs